Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

本發明係有關於一種與IL-20受體所引導之訊息途徑有關之病症(如骨質疏鬆、腎臟衰竭或糖尿病性腎病變)的治療,其係使用抑制IL-20受體活性之藥劑,如經由結合IL-20R1而中和IL-20受體之抗體、以及抑制IL-20R1表現之反義核酸。
Original languageEnglish
Patent numberI448298
Publication statusPublished - 1800

Cite this

@misc{d7eef75f0bfc44a0a8f6d351b5a0f04c,
title = "Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity",
abstract = "本發明係有關於一種與IL-20受體所引導之訊息途徑有關之病症(如骨質疏鬆、腎臟衰竭或糖尿病性腎病變)的治療,其係使用抑制IL-20受體活性之藥劑,如經由結合IL-20R1而中和IL-20受體之抗體、以及抑制IL-20R1表現之反義核酸。",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "I448298",

}

TY - PAT

T1 - Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - 本發明係有關於一種與IL-20受體所引導之訊息途徑有關之病症(如骨質疏鬆、腎臟衰竭或糖尿病性腎病變)的治療,其係使用抑制IL-20受體活性之藥劑,如經由結合IL-20R1而中和IL-20受體之抗體、以及抑制IL-20R1表現之反義核酸。

AB - 本發明係有關於一種與IL-20受體所引導之訊息途徑有關之病症(如骨質疏鬆、腎臟衰竭或糖尿病性腎病變)的治療,其係使用抑制IL-20受體活性之藥劑,如經由結合IL-20R1而中和IL-20受體之抗體、以及抑制IL-20R1表現之反義核酸。

M3 - Patent

M1 - I448298

ER -